Chronic Conditions
Neuromyelitis Optica Spectrum Disorder
Living with NOSD is a challenge. Let TwelveStone make life easier with a care team built around you to support life with a chronic condition.Neuromyelitis Optica Spectrum Disorder Medications
TwelveStone Health Partners provides specialized care coordination and infusion services for patients who have been prescribed biologic therapy for neuromyelitis optica spectrum disorder (NMOSD) at 30+ regional locations. Working alongside your prescribing neurologist, our clinical team supports your prescribed relapse-prevention therapy through medication administration, monitoring, and coordinated care.
Our team supports the key logistics around your prescribed therapy, including benefits verification, prior authorization, copay assistance resources, and scheduling. Contact us to start the intake process and learn what information we need to coordinate your prescribed treatment.

Where Infusion Therapy Fits in NMOSD Relapse Prevention
NMOSD is an autoimmune disorder that most often affects the optic nerves and spinal cord. Relapses can cause vision loss, weakness, numbness, and other neurologic symptoms, and repeated attacks may lead to lasting disability. For that reason, preventing future relapses is a major goal of long-term NMOSD treatment.
NMOSD care includes treating acute attacks and reducing the risk of future relapses. Acute attacks are managed by a neurology or emergency care team and may involve treatments such as high-dose corticosteroids or plasma exchange. TwelveStone supports the outpatient phase after your neurologist prescribes a relapse-prevention therapy, including infusion administration and treatment coordination when appropriate.
Your neurologist may use AQP4-IgG testing, MRI findings, and your clinical history to help diagnose NMOSD and distinguish it from conditions with overlapping features, including multiple sclerosis and MOG antibody-associated disease (MOGAD). AQP4-IgG status also affects treatment eligibility because FDA-approved targeted NMOSD therapies are indicated for adults who are AQP4-antibody positive. Your neurologist will determine which therapy is appropriate for your individual condition.
Once your neurologist prescribes a therapy that TwelveStone can support, our team can help verify benefits, coordinate authorization, and schedule treatment at an appropriate location. Contact us to confirm medication and location availability and begin the intake process.
FDA-Approved NMOSD Biologics: Infusion and Injection Options
Four targeted biologic therapies are FDA-approved in the United States for adults with NMOSD who are anti-AQP4 antibody positive: eculizumab, ravulizumab, inebilizumab, and satralizumab. They work through different immune pathways and are administered either by intravenous infusion or subcutaneous injection. Your neurologist will determine which option is appropriate based on your medical history, treatment goals, dosing schedule, safety considerations, and other individual factors.
| Treatment Approach | Infusion or Injection Option |
|---|---|
| Complement C5 inhibitors | Eculizumab (Soliris) and ravulizumab (Ultomiris) are administered by intravenous infusion for NMOSD. Because these medications increase the risk of serious meningococcal infection, patients must follow meningococcal vaccination requirements, and prescribers must comply with the ULTOMIRIS and SOLIRIS REMS program. |
| B-cell depletion | Inebilizumab (Uplizna) is administered by intravenous infusion. Treatment begins with two initial doses two weeks apart, followed by maintenance infusions every six months as prescribed. TwelveStone provides Uplizna infusion care for eligible adults with NMOSD and coordinates treatment with the prescribing physician. |
| IL-6 receptor blockade | Satralizumab (Enspryng) is administered as a subcutaneous injection. After appropriate training from a healthcare professional, eligible patients or caregivers may administer the medication at home according to the prescribed schedule. |
Rituximab is also used off-label for some patients with NMOSD, although it is not FDA-approved specifically for this condition. Decisions about continuing rituximab or changing to another preventive therapy should be made with your neurologist based on your individual clinical needs.
For infusion therapies supported by TwelveStone, our team works with your prescribing office on referral intake, benefits verification, prior authorization, scheduling, and clinical administration.
What to Expect During Your Infusion Visit

Your visit at a TwelveStone infusion center follows a structured process that may vary depending on your prescribed medication and treatment plan. Care is provided in a private treatment suite, with clinical monitoring throughout the infusion and amenities such as Wi-Fi, television, and refreshments available at participating locations.
- Check-in and assessment: Your care team confirms your treatment information, reviews relevant health updates, and records baseline vital signs before the infusion begins.
- IV or access placement: A licensed clinical team member establishes IV access or uses an appropriate existing access device, depending on your treatment order.
- Pre-medications, when required: Depending on your prescribed therapy, your treatment plan may include medications given before the infusion to help reduce the risk or severity of infusion-related reactions.
- Infusion and monitoring: Your prescribed medication is administered according to its ordered infusion rate while the clinical team monitors you throughout treatment.
- Post-infusion observation: Depending on the medication and your treatment protocol, you may remain at the center for monitoring after the infusion is complete.
- Discharge instructions: Before you leave, your care team reviews any medication-specific precautions, follow-up instructions, and symptoms that should prompt you to contact your provider or seek urgent medical care.
Before your appointment, follow any preparation instructions provided for your specific medication. Unless your care team advises otherwise, staying well hydrated may make IV placement easier, and comfortable clothing with loose or adjustable sleeves can help with access.
You may also bring a book, headphones, or another activity for longer visits. If your care team tells you that a pre-medication may cause drowsiness, arrange transportation home in advance.
After treatment, follow the discharge instructions provided by your clinical team and report new or concerning symptoms as directed. Contact TwelveStone before your appointment if you have questions about preparation, visit length, or what to expect with your prescribed therapy.
Your Path to NMOSD Infusion Care
Once your neurologist prescribes an infusion therapy that TwelveStone supports, our team helps coordinate the steps between referral and treatment. We work with you, your prescribing provider, and your insurer to manage applicable authorization, medication, and scheduling requirements while supporting the treatment plan ordered by your neurologist.
Our care coordination team can assist with the key steps required to get your prescribed infusion scheduled:
TwelveStone operates 30+ infusion centers across the Southeast, giving patients multiple options for community-based treatment. Medication safety is supported by PharmD professionals and experienced infusion clinicians, with care coordinated alongside your prescribing provider.
Organizational Resources

The Guthy-
Jackson Charitable Foundation
is a voluntary, non-profit organization dedicated to funding basic and clinical research needed to treat and cure Neuromyelitis Optica (NMO).

The Sumaira Foundation is a 501(c)(3) organization dedicated to generating global awareness of NMOSD and MOGAD, building communities of support for patients and their caregivers, supporting research and patient advocacy.
The National Multiple Sclerosis Society is a nonprofit organization dedicated to supporting individuals affected by multiple sclerosis and funding research to find a cure for the disease
New Patient Resources
Ready to begin? When you contact TwelveStone, have your insurance information and any available details about your prescribing provider and ordered medication nearby. Our team can explain what additional information or documentation is needed to move your referral forward.

Common Questions About NMOSD Infusion Therapy

If you have a prescribed infusion therapy and need help with referral, insurance verification, authorization, or scheduling, contact TwelveStone Health Partners to speak with a care coordinator.













